290 related articles for article (PubMed ID: 20408737)
1. Safety of intravenous immunoglobulin treatment.
Caress JB; Kennedy BL; Eickman KD
Expert Opin Drug Saf; 2010 Nov; 9(6):971-9. PubMed ID: 20408737
[TBL] [Abstract][Full Text] [Related]
2. Common variable immune deficiency and treatment with intravenous immunoglobulin during pregnancy.
Brinker KA; Silk HJ
Ann Allergy Asthma Immunol; 2012 Jun; 108(6):464-5. PubMed ID: 22626605
[No Abstract] [Full Text] [Related]
3. Intravenous immunoglobulin: an emerging treatment for immune-mediated skin diseases.
Rütter A; Luger TA
Curr Opin Investig Drugs; 2002 May; 3(5):713-9. PubMed ID: 12090544
[TBL] [Abstract][Full Text] [Related]
4. Recurrent multi-organism keratoconjunctivitis manifesting as a first presentation of common variable immune deficiency (CVID).
Ooi KG; Joshua F; Broadfoot A
Ocul Immunol Inflamm; 2007; 15(5):403-5. PubMed ID: 17972226
[TBL] [Abstract][Full Text] [Related]
5. Immunomodulatory effects of intravenous immunoglobulins as a treatment for autoimmune diseases, cancer, and recurrent pregnancy loss.
Sapir T; Blank M; Shoenfeld Y
Ann N Y Acad Sci; 2005 Jun; 1051():743-78. PubMed ID: 16127014
[TBL] [Abstract][Full Text] [Related]
6. [Acute disseminated encephalomyelitis as initial clinical manifestation of common variable immunodeficiency. A case report].
Vella FS; Simone B; Carella A; Schiraldi O; Antonaci S
Recenti Prog Med; 2000; 91(7-8):365-7. PubMed ID: 10932921
[TBL] [Abstract][Full Text] [Related]
7. The role of intravenous immunoglobulin therapy in autoimmune and inflammatory disorders.
Emmi L; Chiarini F
Neurol Sci; 2002 Apr; 23 Suppl 1():S1-8. PubMed ID: 12032582
[TBL] [Abstract][Full Text] [Related]
8. Diffuse normolipemic plane xanthoma in a child with common variable immunodeficiency.
Cambiaghi S; Boneschi V; Maffeis L; Gelmetti C
Pediatr Dermatol; 2011; 28(1):65-6. PubMed ID: 21276061
[TBL] [Abstract][Full Text] [Related]
9. [Intravenous administration of immunoglobulin--preparations and theoretical basis of their use].
Jankowski A
Postepy Hig Med Dosw; 2002; 56 Suppl():5-12. PubMed ID: 12661409
[TBL] [Abstract][Full Text] [Related]
10. Effect of regular intravenous immunoglobulin therapy on prevention of pneumonia in patients with common variable immunodeficiency.
Pourpak Z; Aghamohammadi A; Sedighipour L; Farhoudi A; Movahedi M; Gharagozlou M; Chavoshzadeh Z; Jadid L; Rezaei N; Moin M
J Microbiol Immunol Infect; 2006 Apr; 39(2):114-20. PubMed ID: 16604243
[TBL] [Abstract][Full Text] [Related]
11. Myocardial infarction during intravenous immunoglobulin infusion in a 65-year-old man with common variable immunodeficiency and subsequent successful repeated administration.
Davé S; Hagan J
Ann Allergy Asthma Immunol; 2007 Dec; 99(6):567-70. PubMed ID: 18219840
[TBL] [Abstract][Full Text] [Related]
12. [Personal experience with replacement therapy with intravenous gamma globulin].
Litzman J; Lokaj J; Stikarovská D; Mayer J; Thon V; Eibl MM
Vnitr Lek; 1995 Nov; 41(11):759-63. PubMed ID: 8553594
[TBL] [Abstract][Full Text] [Related]
13. The use of intravenous immunoglobulin in autoimmune bullous diseases.
Chee SN; Murrell DF
Immunol Allergy Clin North Am; 2012 May; 32(2):323-30, viii. PubMed ID: 22560145
[TBL] [Abstract][Full Text] [Related]
14. [Common variable immunodeficiency concomitant with liver cirrhosis--case report].
Macura-Biegun A; Kowalczyk D
Przegl Lek; 2002; 59(6):472-3. PubMed ID: 12418290
[TBL] [Abstract][Full Text] [Related]
15. [Intravenous immunoglobulin therapy].
Mouthon L
Rev Prat; 2005 May; 55(10):1049-56. PubMed ID: 16097244
[TBL] [Abstract][Full Text] [Related]
16. [Use of intravenous immunoglobulin preparations (IVIG) in treatment of primary cell immunodeficiencies].
Siwińska-Gołebiowska H; Czerwińska-Kartowicz I; Markiewicz K
Postepy Hig Med Dosw; 2002; 56 Suppl():33-40. PubMed ID: 12661412
[TBL] [Abstract][Full Text] [Related]
17. [Intravenous immunoglobulin treatment in autoimmune diseases].
Danieli MG; Calcabrini L; Marchetti A; Calabrese V; Pettinari L; Massaccesi C; Gabrielli A; Danieli G
Recenti Prog Med; 2007 Jun; 98(6):322-6. PubMed ID: 17580523
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of action of intravenous immunoglobulin in autoimmune and inflammatory diseases.
Bayry J; Thirion M; Misra N; Thorenoor N; Delignat S; Lacroix-Desmazes S; Bellon B; Kaveri S; Kazatchkine MD
Neurol Sci; 2003 Oct; 24 Suppl 4():S217-21. PubMed ID: 14598046
[TBL] [Abstract][Full Text] [Related]
19. Two young stroke patients associated with regular intravenous immunoglobulin (IVIg) therapy.
Nakano Y; Hayashi T; Deguchi K; Sato K; Hishikawa N; Yamashita T; Ohta Y; Takao Y; Morio T; Abe K
J Neurol Sci; 2016 Feb; 361():9-12. PubMed ID: 26810508
[TBL] [Abstract][Full Text] [Related]
20. Optimal use of ivig in a patient with Behçet syndrome and common variable immunodeficiency.
Shutty B; Garg KJ; Swender D; Chernin L; Tcheurekdjian H; Hostoffer R
Ann Allergy Asthma Immunol; 2012 Jul; 109(1):84. PubMed ID: 22727170
[No Abstract] [Full Text] [Related]
[Next] [New Search]
